Herman Høst

Q: What Schools Are Affiliated With Herman Høst

Herman Høst is affiliated with the following schools: University of Oslo, University of Stavanger

Herman Høst's AcademicInfluence.com Rankings

Herman Høst

Philosophy

#11984

World Rank

#16578

Historical Rank

Logic

#8854

World Rank

#11134

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Herman Høst Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Herman Høst was a Norwegian physician. Høst was born in Bærum as a son of physician Herman Fleischer Høst. He graduated with the cand.med. degree in 1951 and took the dr.med. degree in 1966. He was a chief physician at the Norwegian Radium Hospital from 1974 and a professor of radiological cancer therapy at the University of Oslo from 1975. From 1980 to 1985 he was the dean of the Faculty of Medicine. He was also a member of the Norwegian Academy of Science and Letters. He retired in 1996. Høst died on 14 September 2023, at the age of 97.

(See a Problem?)

Herman Høst's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials (2005) (6940)
Tamoxifen for early breast cancer: an overview of the randomised trials (1998) (3764)
Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. (1994) (877)
Postoperative radiotherapy in breast cancer--long-term results from the Oslo study. (1986) (360)
Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. (1988) (325)
Leukemia following chemotherapy for ovarian cancer (1990) (182)
Age as a prognostic factor in breast cancer (1986) (179)
Second malignancies after treatment of Hodgkin's disease: the influence of treatment, follow-up time, and age. (1993) (164)
The prognostic value of p53 and c‐erb b‐2 immunostaining is overrated for patients with lymph node negative breast carcinoma (2000) (133)
The effect of post-operative radiotherapy in breast cancer. (1977) (132)
Lung cancer following Hodgkin′s disease: A case‐control study (1992) (111)
Role of radiation therapy in small cell anaplastic carcinoma of the lung. (1983) (105)
Leukemia following chemotherapy for ovarian cancer (1990) (98)
Post-mastectomy megavoltage radiotherapy: the Oslo and Stockholm trials. (1992) (92)
Phase I study of the plant protein ricin. (1984) (73)
Postoperative radiotherapy in breast cancer. (1981) (61)
Myelopathy following radiotherapy of bronchial carcinoma with large single fractions: a retrospective study. (1983) (57)
Weekly adriamycin versus VAC in advanced breast cancer. A randomized trial. (1986) (54)
A randomized study evaluating radiotherapy versus chemotherapy in patients with inoperable non-small cell lung cancer. (1988) (38)
Cerebrospinal irradiation of Burkitt's lymphoma. Failure in preventing central nervous system relapse. (1977) (34)
Combined surgery and radiation therapy versus surgery alone in primary mammary carcinoma. I. The effect of orthovoltage radiation. (1975) (32)
Acute and subacute side effects due to infra-diaphragmatic radiotherapy for testicular cancer: a prospective study. (1992) (30)
A preliminary clinical study of cyclophosphamide. (1960) (29)
Systemic pneumococcal disease after staging splenectomy for Hodgkin's disease 1969–1980 without pneumococcal vaccine protection: a follow‐up study 1994 (1997) (28)
Blood tests and prognosis in bladder carcinomas treated with definitive radiotherapy. (1993) (27)
Combination chemotherapy of germ cell tumors of the testis with vincristine, adriamycin, cyclophosphamide, actinomycin D and medroxyprogesterone acetate (1977) (24)
Follow-up of breast cancer patients stage I-II: a baseline strategy. (1993) (23)
Sternberg-Reed cells in the thoracic duct lymph of patients with Hodgkin's disease. A preliminary report. Cytologic studies in connection with lymphography. (1968) (23)
Blood lymphocytes in Hodgkin's disease. Increase of B-lymphocytes following extended field irradiation. (2009) (22)
Reduced short-term neuropsychological performance in patients with nonsmall-cell lung cancer treated with cisplatin and etoposide. (1988) (22)
Cyclophosphamide (NSC-26271) as adjuvant to radiotherapy in the treatment of unresectable bronchogenic carcinoma. (1973) (22)
Lethal acute gamma radiation accident at Kjeller, Norway. Report of a case. (1985) (21)
Treatment of node-negative breast cancer patients with short course of chemotherapy immediately after surgery. (1986) (21)
Comparative effects of cyclophosphamide, nitrogen mustard, and total-body irradiation on survival and on white blood cells in rats. (1966) (21)
Randomized phase II trial of carminomycin versus 4'-epidoxorubicin in advanced breast cancer. (1984) (20)
Cell-associated immunoglobulin in human non-Hodgkin lymphomas. A comparative study of surface immunoglobulin on cells in suspension and cytoplasmic immunoglobulin by immunohistochemistry. (2009) (18)
Laparotomy and splenectomy in the management of Hodgkin's disease. (2009) (17)
Weekly Adriamycin vs. 4-epidoxorubicin every second week in advanced breast cancer. A randomized trial. The Norwegian Breast Cancer Group. (1990) (17)
Multi-modality treatment of advanced malignant germ cell tumours in males. I. Experience with cis-platinum-based combination chemotherapy. (1984) (16)
Short perioperative versus long-term adjuvant chemotherapy. (1985) (16)
Chemotherapy with or without high-dose medroxyprogesterone acetate in oestrogen-receptor-negative advanced breast cancer. Norwegian Breast Cancer Group. (1992) (15)
Distribution of T-cell subsets identified by monoclonal antibodies in cell suspensions from lymph node biopsies of human B-cell lymphomas. (2009) (15)
The role of postoperative radiotherapy in breast cancer (1978) (13)
Mantle field irradiation for stages IA and IIA Hodgkin's disease. (2009) (13)
Is staging laparotomy of therapeutic value in patients with supradiaphragmatic Hodgkins's disease, clinical stage IA-IIA? (2009) (12)
Epirubicin in colorectal cancer. A phase II study of the early clinical trials group (EORTC). (1985) (11)
Scandinavian trials with a short postoperative course versus a 12-cycle course. (1984) (11)
A comparison between the hematological side effects of cyclophosphamide and nitrogen mustard. (1960) (10)
Combination chemotherapy with cyclophosphamide, vinblastine, procarbazine and prednisone in the treatment of malignant lymphomas. (2009) (10)
Regeneration of bone marrow cells in rats following cyclophosphamide or total body irradiation. (1966) (10)
Host markers and prognosis in recurrent rectal carcinomas treated with radiotherapy. (1994) (9)
Cyclical use of tamoxifen and high-dose medroxyprogesterone acetate in advanced estrogen receptor positive breast cancer (1990) (9)
Comparative effects of cyclophosphamide and total body irradiation on erythropoietin production in rats. (2009) (8)
Leukocyte adherence inhibition assay in human pulmonary neoplasia. (1982) (8)
Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. (1987) (8)
Alterations of blood analyses at relapse of osteosarcoma and Ewing's sarcoma. (1990) (7)
The effect of colcemid on bone marrow cells studied by a quantitative method. (1966) (7)
Prolonged adjuvant chemotherapy in breast cancer. The Scandinavian Adjuvant Chemotherapy Study 2. (1989) (7)
Multi-modality treatment in males with advanced malignant germ cell tumours. II. Experience with surgery and radiotherapy following cis-platinum-based chemotherapy. (1984) (6)
The effect of extended-field radiotherapy on peripheral blood values in advanced Hodgkin's disease. (2009) (5)
Benzylidene‐Glucose: No Effect After All? (1990) (4)
Effect of intermittent hypoxia on regeneration of haemopoiesis in rats treated with cyclophosphamide or total body irradiation. (2009) (4)
Phase I/II study of carboplatin and 5-fluorouracil in patients with advanced head and neck carcinoma. (1991) (4)
Early detection of breast cancer by leukocyte adherence inhibition assay. (1983) (4)
Perioperative adjuvant chemotherapy of breast cancer: the Scandinavian experience. (1986) (4)
Effect of prednisone on bone marrow cells regenerating from total body irradiation. (1968) (4)
The value of periodic mass chest roentgenographic surveys in the detection of primary bronchial carcinoma in Norway. (1960) (3)
[Tumor size and histological grading of stage 1 breast cancer. Prognostic and therapeutic significance]. (1996) (3)
[Mithramycin in advanced malignant testicular tumors]. (1975) (3)
Immunologic subsets in B cell lymphomas defined by surface immunoglobulin isotype and complement receptor--their relationship to survival. (2009) (3)
The detection of lung cancer by means of periodic mass chest x-ray surveys. (1959) (2)
Treatment of muscle-infiltrating bladder cancer: the Norwegian Radium Hospital's experience 1966-1982. (1988) (2)
[Primary inoperable carcinoma of the breast]. (1975) (2)
Phase II Evaluation in Patients with Non-Hodgkin’s Lymphoma the Old World Experience — An Interim Report (1985) (2)
Measurements of leukocyte adherence inhibition response in breast cancer patients as a prognostic factor (1985) (2)
A phase II trial of peplomycin in squamous cell carcinoma of the lung. (1983) (2)
Adjuvant immunotherapy in node-negative patients: results of a Scandinavian study. (1989) (2)
Phase II trial of diaziquone (AZQ) in advanced malignant melanoma. (1983) (2)
Weekly anthracycline in the treatment of advanced breast cancer. (1989) (2)
[Infrastructure for clinical research in a hospital]. (1994) (1)
[Anaplastic thyroid carcinomas]. (1986) (1)
[Cytostatic agents and cytostatic therapy]. (1973) (1)
[Clinical experience with bleomycin--a new cytostatic agent for cancer]. (1971) (1)
[A radiation accident with lethal outcome]. (1984) (1)
[A radiation accident with fatal outcome]. (1983) (1)
[Chemotherapy in testicular neoplasms]. (1978) (1)
Effect of splenectomy followed by cyclophosphamide or total body irradiation on hemopoiesis in rats. (1967) (0)
[Treatment of Hodgkin's disease]. (1972) (0)
[Experience with breast-preserving surgery in breast carcinoma]. (1986) (0)
[Pulmonary changes after postoperative 60cobalt-treatment of breast neoplasms]. (1971) (0)
[Ovarian irridation and prednisone versus tamoxifen (Nolvadex) in advanced breast cancer]. (1983) (0)
[Induction therapy in small cell lung carcinoma]. (1985) (0)
Treatment of muscle infiltrating bladder carcinoma by total cystectomy preceded by irradiation (1980) (0)
4′-Epidoxorubicin in Advanced Colorectal Cancer (1983) (0)
Investigations of Blood Pressure in Hypertonia Diseases (2009) (0)
[Malignant lymphoma. New aspects]. (1973) (0)
Erfaringer med ambulant onkolog. (1985) (0)
[Letter: Sociomedical aspects of genetic counseling]. (1975) (0)
Phase II-Study of thermoradiotherapy for locally advanced breast carcinoma (1990) (0)
[Adjuvant therapy in operable breast neoplasms]. (1979) (0)
[Drug therapy of cancer]. (1974) (0)
CYCLPHOSPHAMIDE AS ADJUVANT TO THE SURGICAL TREATMENT OF MALIGNANT MELANOMA, STAGES I AND II. (1964) (0)
[Triethylene melamine in Hodgkin's disease]. (1955) (0)
[Treatment of pain in cancer patients]. (1990) (0)
[Experiences with the travelling oncologist]. (1985) (0)
[Butazolidine therapy of thrombophlebitis]. (1957) (0)
[Cyclophosphamide in myelomatosis]. (1965) (0)
[Malignant testicular tumors]. (1973) (0)
[Cyklokapron in the treatment of neoplasms]. (1978) (0)
[Synovioma; clinical aspects, radiography and treatment]. (1954) (0)
[Preoperative irradiation in carcinoma of the breast]. (1975) (0)
[Chemotherapy of malignant diseases; survey orientation]. (1959) (0)
[Hematological side-effects of cyclophosphamide]. (1961) (0)
Leukemia following chemotherapy for ovarian cancer (1990) (0)
Psychosocial well being and clinical toxicity in a randomized controlled trial of patients with inoperable non-small cell lung cancer (limited disease) (1989) (0)
[Perspective on the nonsurgical treatment of neoplasms in Norway]. (1977) (0)
[Therapy of malignant testicular tumors]. (1968) (0)
[Personality and cancer]. (1989) (0)
[Serum testosterone level in patients with advanced prostatic cancer during androgen suppressive treatment]. (1981) (0)
[Hodgkin's disease or lymphogranulomatosis. New views on prognosis, complicating conditions and complications after treatment]. (1993) (0)
[Treatment of muscle-infiltrating bladder cancer by preoperative irradiation and total cystectomy]. (1980) (0)
[New cancer disease after treatment of Hodgkin's disease]. (1993) (0)
[Clinical experience with cyclophosphamide]. (1961) (0)
[Extravasal injection of cytostatics. Special reference to adriamiycin]. (1983) (0)
Acute and Subacute Side Effects Due to Infra-Diaphragmatic Radiotherapy for Testicular Cancer: A Prospective Study (1993) (0)
[Mesenteric artery compression of duodenum]. (1957) (0)
[In memoriam George Benestad]. (1957) (0)
[The place of anabolic steroids in cancer therapy]. (1969) (0)
Experimental Investigations of Hypertonia (2009) (0)
[Letter: Immunotherapy in malignant melanoma]. (1975) (0)
[Lymphogranulomatosis. Current views]. (1985) (0)
[Cytostatics in general practice]. (1980) (0)
Perioperative adjuvant chemotherapy vs postoperative chemotherapy for one year (1982) (0)
[Breast cancer]. (1973) (0)

This paper list is powered by the following services:

Other Resources About Herman Høst

en.wikipedia.org

What Schools Are Affiliated With Herman Høst?

Herman Høst is affiliated with the following schools: